Lipitor
Trovati 16 articoli
- Lymphoma: statins do not interfere with Rituximab treatment
- Statins, drugs widely prescribed to lower cholesterol, do not interfere with a commonly used medication to treat lymphomas, according to a study presented at the 50th Annual Meeting of the American Society of Hematology ( ASH ) in San Francisco. In fact, statins, also known as HMG-CoA reductase i... (Leggi Articolo)
- Lipitor, interactions and the risk of haemorrhagic stroke in patients with recent stroke
- Pfizer has informed Healthcare Professional of updated prescribing advice for Atorvastatin ( Lipitor ). The new advice relates to interactions and the risk of haemorrhagic stroke in patients with recent stroke. Interactions with other medicines Atorvastatin levels may increase when administ... (Leggi Articolo)
- BHT-3009, a DNA vaccine against multiple sclerosis
- A newly developed DNA vaccine appears safe and may produce beneficial changes in the brains and immune systems of individuals with multiple sclerosis. In patients with multiple sclerosis ( MS ), the immune system attacks the myelin sheaths that protect nerve cells in the brain and spinal cord.... (Leggi Articolo)
- Lack of evidence of a Clopidogrel-statin interaction
- There are conflicting data regarding whether statins predominantly metabolized by CYP3A4 reduce the metabolism of Clopidogrel ( Plavix ) to its active metabolite and diminish its clinical efficacy. CHARISMA investigators evaluated the potential impact of Clopidogrel and statin interaction in a... (Leggi Articolo)
- Torcetrapib fails to slow progression of coronary disease
- Researchers at Cleveland Clinic reported that the drug Torcetrapib, despite raising high density lipoprotein cholesterol ( HDL ) by more than 60%, did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe. All development of Torcetrapib was... (Leggi Articolo)
- PPAR-alpha agonists: LY518674 shows no advantages compared with Fenofibrate
- Researchers at Cleveland Clinic have recently completed a pair of studies to determine the safety and efficacy of a new, potent type of cholesterol treatment known as a peroxisome proliferator-activated receptor alpha ( PPAR-alpha ) agonist. The new drug, LY518674 ( LY5 ) is similar to an existin... (Leggi Articolo)
- Seeking to prevent tumor using anti-inflammatory agents
- Mayo Clinic Cancer Center has begun three clinical studies looking at the use of nonsteroidal anti-inflammatory drugs ( NSAIDs ) to prevent cancer ( colon, esophageal or lung ). These studies are part of the ongoing Cancer Center chemoprevention program, using medications to prevent cancer, espec... (Leggi Articolo)
- Statins improve erectile dysfunction of some men with minimal reaction to Sildenafil
- Results of a small study showed promise in improving erectile dysfunction in men who had shown minimal reaction to Sildenafil ( Viagra ). The study results are published in the Journal of Sexual Medicine. Erectile dysfunction is often a sign of a more severe vascular problem that involves... (Leggi Articolo)
- Vytorin reduces LDL cholesterol better than Lipitor in diabetes mellitus type 2
- Results from a new prespecified analysis of the VYVA ( VYtorin Versus Atorvastatin ) trial involving a subgroup of 428 patients with type 2 diabetes were consistent with the overall VYVA trial. In this new analysis, results showed that Vytorin ( Ezetimibe/Simvastatin ), provided 56% reduction... (Leggi Articolo)
- FDA: Lipitor approved to reduce stroke and myocardial infarction risk in patients with type 2 diabetes
- The FDA ( Food and Drug Administration ) has approved Lipitor ( Atorvastatin ) a cholesterol-lowering drug, to reduce the risk of stroke and heart attack in people with type 2 diabetes without evidence of heart disease but with other risk factors. Lipitor also received approval to reduce the ris... (Leggi Articolo)
- Erectile dysfunction: irreversible vision loss due phosphodiesterase 5 inhibitors
- Public Citizen, representing more than 135,000 U.S. consumers, submitted a petition to the FDA ( Food and Drug Administration ) to immediately add a black box warning regarding the risks of drug-induced blindness for the three phosphodiesterase 5 ( PDE5 ) inhibitors that are prescribed for the tr... (Leggi Articolo)
- Coronaropathy: high-versus low dose Lipitor
- The Third Report of the National Cholesterol Education Program ( NCEP ) - Adult Treatment Panel and the most recent guidelines of the Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice have recommended an LDL cholesterol level of less ... (Leggi Articolo)
- Advanced prostate carcinoma: statins may reduce the risk
- Use of statins may reduce the risk of advanced prostate cancer, according to research that followed 34,428 U.S. men for more than a decade. The study found that men who used these medications had half the risk of advanced prostate cancer and a third of the risk of metastatic or fatal prostate ... (Leggi Articolo)
- CT scanning predicts heart attack more accurately than CRP
- The St. Francis Heart Study demonstrated that fast CT scanning of the coronary arteries predicts coronary events such as heart attack independently of and more accurately than conventional risk factors such as age, smoking, blood pressure and cholesterol, and C-reactive protein ( CRP ). The st... (Leggi Articolo)
- Alzheimer’s disease: treatment with Atorvastatin may be of some clinical benefit
- Treatment with Atorvastatin ( Lipitor ), a cholesterol-lowering drug, may be of some clinical benefit on measures of cognitive and psychiatric symptoms in patients with mild to moderate Alzheimer disease. Laboratory evidence of cholesterol-induced production of amyloid beta, along with epidemi... (Leggi Articolo)
- Metabolic syndrome: treatment
- A study presented at the 40th Annual Meeting of the European Association for the Study of Diabetes ( EASD ), Munich, Germany, has showed that Rosuvastatin ( Crestor ) lowers LDL-cholesterol and raises HDL-cholesterol significantly more than Atorvastatin ( Lipitor ) in patients with the metaboli... (Leggi Articolo)
